Regenxbio prices 1,111,111 pre-funded warrants at USD 9 in public offering
RGNX•Public offering priced
Regenxbio priced a public offering that includes 1,111,111 pre-funded warrants at USD 9 per warrant.
Warrants were priced at USD 9.00 per warrant, before underwriting discounts and commissions.
Expected proceeds and timing
Gross proceeds are expected to be about USD 100 million, before fees and expenses. Closing is targeted for July 20, 2026.
